MRX Technologies USA Counter-Terrorism operations in 27 time zones. Rapid development of advanced technological countermeasures.
Exploiting deficiencies within systems. Scientific innovations of global significance, altering the trajectory of markets and economies.
Individual Specific Targeting without collateral damage to other persons or property.
Medically, every human emits an orchestration of emissions that can be monitored, providing a plethora of information, including the specific identity of an individual. A new generation of sensors provides this information and is technologically far removed from the “Remote Sensing” of the past. For “illustrative” purposes, this closely held proprietary technology is being referred to as “Holographic Sensors”.
In 2023, MRX remains privately held, with operations in over 130 Countries, comprised of more than 350 Corporations, employing over 28,000, generating annual revenues of $53.64B USD.
